X-154532701-A-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001360016.2(G6PD):c.1153T>C(p.Cys385Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C385F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Publications
- anemia, nonspherocytic hemolytic, due to G6PD deficiencyInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- G6PD deficiencyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- class I glucose-6-phosphate dehydrogenase deficiencyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001360016.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PD | NM_001360016.2 | MANE Select | c.1153T>C | p.Cys385Arg | missense | Exon 10 of 13 | NP_001346945.1 | ||
| G6PD | NM_000402.4 | c.1243T>C | p.Cys415Arg | missense | Exon 10 of 13 | NP_000393.4 | |||
| G6PD | NM_001042351.3 | c.1153T>C | p.Cys385Arg | missense | Exon 10 of 13 | NP_001035810.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PD | ENST00000393562.10 | TSL:1 MANE Select | c.1153T>C | p.Cys385Arg | missense | Exon 10 of 13 | ENSP00000377192.3 | ||
| G6PD | ENST00000696421.1 | c.1153T>C | p.Cys385Arg | missense | Exon 10 of 13 | ENSP00000512616.1 | |||
| G6PD | ENST00000369620.6 | TSL:5 | c.1291T>C | p.Cys431Arg | missense | Exon 10 of 13 | ENSP00000358633.2 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
G6PD TOMAH Pathogenic:1Other:1
This variant has previously been described as pathogenic including in a patient with chronic non-spherocytic haemolytic anaemia (PMID: 2602358). Functional characterization of the variant demonstrated severely reduced function (PMID: 2602358). The variant is not present in public reference databases, and is thus presumed rare. The residue is conserved within vertebrates, and the substitution of an arginine residue is predicted to be damaging by in silico methods. There are additional reports of different amino acid substitutions at this residue also as pathogenic (PMID: 9410474, 9332310, 28028996). This variant was found in the hemizygous state, and was maternally inherited. Based on the available evidence, the variant is classified as pathogenic.
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:1
Variant found in unrelated hemizygotes with deficiency and CNSHA (PS4_M, PP4). Decreased activity in red blood cells (1-11%) (PS3). Within dimer interface (PM1). Predicted to be pathogenic or deleterious by several in silico tools (PP3). Not found in gnomAD (PM2). Post_P 0.999 (odds of pathogenicity 6568, Prior_P 0.1).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at